Danaher Corporation

Improving the efficiency and quality of advanced imaging and analysis

Danaher Corporation

Breaking the Bottlenecks: Enhancing Throughput and Reproducibility in Proteomic Analysis

Danaher Corporation

Tackling High Costs of Developing AAV-Based Therapeutics

Danaher Corporation

Eliminating Analytical Bottlenecks and Streamlining Drug Discovery

Danaher Corporation

Overcoming Bottlenecks and Streamlining High-Throughput Screening for Drug Development

Danaher Corporation

Realizing Gene Therapy’s Potential: Conquering Challenges in Viral Vector Production

Danaher Corporation

Improving Drug Development Efficiency with Human-Relevant 3D Systems

Danaher Corporation

Going beyond the mAb: streamlining cell line development for Antibodies

Danaher Corporation

Collaboration is key to Advancing Cell and Gene Therapy